CLAIM CARD
Within the corpus, notable tensions emerge between studies reporting positive or mixed findings and those yielding null or unclear results. The systematic review of curcumin for rheumatoid arthritis by Fan 2026 (mixed effect direction) reports highly significant pooled effects, whereas Liu 2025 found no significant effect of curcumin on inflammatory biomarkers in RA and SLE patients, representing a direct disagreement within the autoimmune inflammation domain. These discrepancies across tension pairs highlight that curcumin's clinical benefit remains context-dependent, with formulation, dosage, and disease state as critical moderators of observed efficacy.
Evidence grade: exploratory
Contradiction status: none
Publication: 2ed54f5a-fbc9-45ec-8fa9-5be79af12b17
Provenance: Derivation Web chain
Citation Support
source_1Flensted-Jensen 2025source_2Flensted-Jensen 2025bsource_3Xu 2025source_4El-Rakabawy 2025source_5Schonenberger 2025